|
Haemonetics® Corporation a global leader in blood management solutions based in Braintree, Massachusetts, has acquired the trade
name SEBRA and its Biological Collection and Processing Product line. This product line includes equipment for blood banks, commercial
plasma centers, stem cell processing facilities, and hospitals. Equipment includes whole blood collection devices, radio frequency (RF)
tube sealers, and mobile lounges.
Haemonetics helps hospitals, blood and plasma collectors to improve patient care and lower costs by optimizing the collections, processing,
and use of scarce blood resources. The Company's broad product offering includes blood collection and separation technologies, surgical
blood salvage systems, information technology platforms, and consulting services that improve blood management practices.
As a leader in blood management solutions, Haemonetics brings extensive knowledge of the industry to its partners. The addition of the
SEBRA suite of products broadens Haemonetics portfolio of solutions into the whole blood market, thereby offering customers' more options.
To learn more about Haemonetics' offerings, visit www.haemonetics.com.
|
